0001415889-22-001792.txt : 20220224
0001415889-22-001792.hdr.sgml : 20220224
20220224173027
ACCESSION NUMBER: 0001415889-22-001792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huber Martin H. Jr.
CENTRAL INDEX KEY: 0001653276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 22672899
MAIL ADDRESS:
STREET 1: C/O TESARO, INC.
STREET 2: 1000 WINTER STREET, SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-02242022_050208.xml
X0306
4
2022-02-22
0001840233
Xilio Therapeutics, Inc.
XLO
0001653276
Huber Martin H. Jr.
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
false
true
false
false
PRESIDENT OF R&D AND CMO
Stock Option (right to buy)
12.66
2022-02-22
4
A
0
65000
0
A
2032-02-21
Common Stock
65000
65000
D
The option award was granted on February 22, 2022 and shall vest on March 1, 2022 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until February 1, 2026.
/s/ Chris Frankenfield, Attorney-in-Fact
2022-02-24